PD-1 Combined With Bevacizumab and PCSK-9 Inhibitor in Patients With Advanced NSCLC Who Have Progressed After Anti- PD- 1/L1 Therapy

Name: PD-1 Combined With Bevacizumab and PCSK-9 Inhibitor in Patients With Advanced NSCLC Who Have Progressed After Anti- PD- 1/L1 Therapy
License: Public Domain

Anhui Provincial Cancer Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

nsclc (advanced non-small cell lung cancer), resistance to immunotherapy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 184828
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.